TI

Trends in Molecular Medicine

Trends in Molecular Medicine publishes concise and contextualized reviews and opinions on research at the interface between basic biology and clinical research, with emphasis on mechanisms of human biology and pathology that have implications for diagnostics, therapeutics, prevention, and human disease. The journal covers themes including disease mechanisms, tools and technologies, diagnostics, therapeutics, clinical trial landscape, science policy, and medical ethics, with a goal of bridging bench and bedside for a broad audience.

Looking to publish in Trends in Molecular Medicine? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Medicine, Research & Experimental
Impact Factor 13.8
Quartile Q1
Open Access Type Hybrid
ISSN 1471-4914
eISSN 1471-499X
Invitation Only No
Cost Range APC fees start at US$1500 excluding tax; Trends review journals are listed at US$7,030 for hybrid open access.

Submission Instructions

Trends in Molecular Medicine accepts the following article types. Click on an article type to view submission instructions.

Review

Cover Letter Cover Letter requirements are not specified.
Abstract Review articles must include an abstract. Review abstracts must be 100–120 words.
Manuscript Review main text must be 3000–3500 words. Review articles should begin with a short introductory section of one or two paragraphs under a descriptive heading other than “Introduction” and end with a section entitled “Concluding Remarks.” Review articles must include at least four descriptive keywords, Highlights of 3–5 bullet points not exceeding 900 characters in a separate Word file, an Outstanding Questions box not exceeding 2000 characters in a separate Word file, a 200–400 word Clinician’s Corner of 4–5 bullet points, a declaration of interests section, and an AI declaration statement if generative AI was used in writing.
References Review articles must include no more than 100 references. References must be numbered in square brackets in order of appearance in the text, while websites should be cited in the main text in parentheses rather than included in the reference list.
Figures & Tables Review articles may contain up to six display elements, and only one Key Figure or one Key Table may be included, not both. Figures must be uploaded as separate files rather than embedded in the main text document, while tables must be included in the main manuscript file in Word format and not submitted as separate image files. Figure legends must have a short explanatory title, fully explain the figure without reference to the text, and be no more than 250 words, while tables must have a single-sentence title and no legend.
Reformat to Trends in Molecular Medicine using Livewrite Premium

Letters

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Letters must be 700–800 words. Letters must include at least two descriptive keywords and the manuscript must include a declaration of interests section plus a separate AI declaration statement if generative AI or AI-assisted writing tools were used.
References Letters must include no more than 12 references. References must be numbered and cited in the text in square brackets in the order they appear.
Figures & Tables Letters may contain one display element. Letter figures must be supplied as separate files rather than embedded in the main text document, while Letter tables must be submitted as part of the main document. Letter figure legends must have a short explanatory title and fully explain the figure without reference to the text, and Letter tables must have a single-sentence title with abbreviations explained in footnotes using superscript lowercase letters.
Reformat to Trends in Molecular Medicine using Livewrite Premium

Recent Publications

Targeting ferroptosis halts graft deterioration in transplantation

Chunheng Mo

10.1016/j.molmed.2026.06.005
View Publication

Amyotrophic lateral sclerosis: A rare but aggressive adult-onset disease

Luca Brodribb, Phil Camden, Thanuja Dharmadasa, Catherine Blizzard

10.1016/j.molmed.2026.06.001
View Publication

Urticaria: A debilitating disorder with emerging therapies

Dimitra Gialama, Martin Metz, Pavel Kolkhir

10.1016/j.molmed.2026.06.003
View Publication

Gene therapy for aging and longevity

Stacia P.A. Everts, Michael Florea, João Pedro de Magalhães

10.1016/j.molmed.2026.05.007
View Publication

The emerging role of PPARs in primary biliary cholangitis

Xavier Palomer, Ricardo Rodríguez-Calvo, Sandra García-Mateo, Walter Wahli, Manuel Vázquez-Carrera

10.1016/j.molmed.2026.05.008
View Publication

Frequently asked questions

How long does it take to publish?

What are the publication costs?

APCs start at US$1500 excluding tax. Trends review journals are listed at US$7,030 for hybrid open access, excluding taxes.

Reformat to Trends in Molecular Medicine using Livewrite Premium

Research Topics

Diverse Scientific and Economic Studies Human auditory perception and evaluation Legal Cases and Commentary Immune Cell Function and Interaction Legal case studies and regulations Immunotherapy and Immune Responses CRISPR and Genetic Engineering Epigenetics and DNA Methylation T-cell and B-cell Immunology Virus-based gene therapy research Mitochondrial Function and Pathology RNA Interference and Gene Delivery RNA modifications and cancer Pluripotent Stem Cells Research Educational Robotics and Engineering CAR-T cell therapy research Alzheimer's disease research and treatments MicroRNA in disease regulation Neuroinflammation and Neurodegeneration Mechanisms Pharmacy and Medical Practices RNA Research and Splicing Cancer-related Molecular Pathways Cancer, Hypoxia, and Metabolism Ubiquitin and proteasome pathways Cancer Genomics and Diagnostics

Related Journals

WR
Wound Repair and Regeneration WILEY
LP
La Presse Médicale Elsevier BV
DR
Diabetes Research and Clinical Practice Elsevier BV
JO
Journal of the Neurological Sciences Elsevier BV
P&
Pharmacology & Therapeutics Elsevier BV
NC
NeuroImage Clinical Elsevier BV